Shingrix

Pharma

GSK raises long-term sales goal—again—despite vaccines woes

After re-adding Blenrep to its portfolio, GSK now expects sales to reach more than £40 billion in 2031. The company's previous target was £38 billion.

Angus Liu Feb 5, 2025 11:06am

Sanofi, GSK and China reimbursement updates—Fierce Pharma Asia

Dec 6, 2024 9:00am

GSK cuts Shingrix deliveries in revised Zhifei China pact

Dec 5, 2024 10:52am

GSK's RSV vaccine sales plummet in wake of guidance changes

Oct 30, 2024 10:41am

GSK touts co-administration data for RSV, shingles vaccines

Sep 18, 2024 11:22am

Brooke Shields photographed by Pamela Hanson for GSKs THRIVE50 campaign

GSK makes Brooke Shields the star of shingles vaccination push

Sep 17, 2024 5:45am